Clinical Trial

The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to describe patients' satisfaction with Patient Support Program (Balance Program), Quality of Life and depression symptoms, dosing pattern, disease symptoms, adverse events and nintedanib discontinuation (both permanent and non-permanent) from study inclusion to 12 months of follow-up.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2025-04-03; most recent amendment 2026-01-07.
Status change: Recruiting → Active, Not Recruiting 2026-01-07
Status change: Not Yet Recruiting → Recruiting 2025-06-27
Trial Details
NCT Number NCT06912659
Lead Sponsor Boehringer Ingelheim
Conditions Pulmonary Fibrosis
Enrollment 157 participants
Start Date 2025-06-23
Primary Completion 2026-12-23 (estimated)
Study Completion 2026-12-23 (estimated)
Updated on ClinicalTrials.gov 2026-01-08